• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of arginine therapy on kyotorphin in children with sickle cell disease and vaso-occlusive pain.

作者信息

Korman Rawan, Hatabah Dunia, Brown Lou Ann, Harris Frank, Wilkinson Hagar, Rees Chris A, Bakshi Nitya, Archer David R, Dampier Carlton, Morris Claudia R

机构信息

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.

Children's Healthcare of Atlanta, Atlanta, GA.

出版信息

Blood Adv. 2024 Jun 25;8(12):3267-3271. doi: 10.1182/bloodadvances.2023012209.

DOI:10.1182/bloodadvances.2023012209
PMID:38527291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11226964/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3f/11226964/d44c70368acd/BLOODA_ADV-2023-012209-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3f/11226964/38d5a0c8ec4f/BLOODA_ADV-2023-012209-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3f/11226964/0ecee2e736c2/BLOODA_ADV-2023-012209-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3f/11226964/d44c70368acd/BLOODA_ADV-2023-012209-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3f/11226964/38d5a0c8ec4f/BLOODA_ADV-2023-012209-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3f/11226964/0ecee2e736c2/BLOODA_ADV-2023-012209-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3f/11226964/d44c70368acd/BLOODA_ADV-2023-012209-gr2.jpg

相似文献

1
Impact of arginine therapy on kyotorphin in children with sickle cell disease and vaso-occlusive pain.精氨酸疗法对镰状细胞病和血管闭塞性疼痛患儿中京都啡肽的影响。
Blood Adv. 2024 Jun 25;8(12):3267-3271. doi: 10.1182/bloodadvances.2023012209.
2
Safety of intravenous arginine therapy in children with sickle cell disease hospitalized for vaso-occlusive pain: A randomized placebo-controlled trial in progress.镰状细胞病患儿因血管闭塞性疼痛住院时静脉注射精氨酸治疗的安全性：一项正在进行的随机安慰剂对照试验。
Am J Hematol. 2022 Jan 1;97(1):E21-E24. doi: 10.1002/ajh.26396. Epub 2021 Nov 12.
3
Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain.精氨酸治疗对镰状细胞病血管阻塞性疼痛患儿线粒体功能的影响。
Blood. 2020 Sep 17;136(12):1402-1406. doi: 10.1182/blood.2019003672.
4
Association between baseline fetal hemoglobin levels and incidence of severe vaso-occlusive pain episodes in children with sickle cell anemia.镰状细胞贫血患儿基线胎儿血红蛋白水平与严重血管阻塞性疼痛发作发生率的关系。
Pediatr Blood Cancer. 2013 Oct;60(10):E125-7. doi: 10.1002/pbc.24588. Epub 2013 May 15.
5
A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.一项关于精氨酸治疗用于治疗镰状细胞病患儿血管阻塞性疼痛发作住院患者的随机、安慰剂对照试验。
Haematologica. 2013 Sep;98(9):1375-82. doi: 10.3324/haematol.2013.086637. Epub 2013 May 3.
6
Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.DOVE（确定血小板抑制对血管闭塞事件的影响）试验设计：一项全球性3期双盲、随机、安慰剂对照、多中心研究，采用剂量滴定策略评估普拉格雷在镰状细胞贫血儿科患者中的疗效和安全性。
Pediatr Blood Cancer. 2016 Feb;63(2):299-305. doi: 10.1002/pbc.25771. Epub 2015 Sep 24.
7
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.聚氧乙烯月桂醚 188 对比安慰剂对镰状细胞病儿童和成人血管阻塞性危象疼痛的影响：一项随机临床试验。
JAMA. 2021 Apr 20;325(15):1513-1523. doi: 10.1001/jama.2021.3414.
8
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.一项评估普拉格雷治疗镰状细胞血管阻塞事件的多国临床试验。
N Engl J Med. 2016 Feb 18;374(7):625-35. doi: 10.1056/NEJMoa1512021. Epub 2015 Dec 8.
9
Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain.生理盐水推注在儿科急诊中与镰状细胞贫血和血管阻塞性疼痛患儿的疼痛控制较差有关。
Am J Hematol. 2019 Jun;94(6):689-696. doi: 10.1002/ajh.25471. Epub 2019 Apr 29.
10
Comment on: Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease.关于《氯胺酮用于小儿镰状细胞病血管闭塞性疼痛的管理》的评论
Pediatr Blood Cancer. 2023 Nov;70(11):e30618. doi: 10.1002/pbc.30618. Epub 2023 Aug 9.

引用本文的文献

1
Arginine Therapy for Pain in Sickle Cell Disease: A Phase-2 Randomized, Placebo-Controlled Trial.精氨酸治疗镰状细胞病疼痛：一项2期随机、安慰剂对照试验
Am J Hematol. 2025 Jul;100(7):1119-1131. doi: 10.1002/ajh.27692. Epub 2025 Apr 24.

本文引用的文献

1
Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial.用精氨酸治疗镰状细胞病（STArT）：一项 3 期随机对照试验的研究方案。
Trials. 2023 Aug 17;24(1):538. doi: 10.1186/s13063-023-07538-z.
2
Effects of l-arginine supplementation in patients with sickle cell disease: A systematic review and meta-analysis of clinical trials.补充L-精氨酸对镰状细胞病患者的影响：一项临床试验的系统评价和荟萃分析。
Health Sci Rep. 2023 Apr 11;6(4):e1167. doi: 10.1002/hsr2.1167. eCollection 2023 Apr.
3
Amino acid signature during sickle cell pain crisis shows significant alterations related to nitric oxide and energy metabolism.
镰状细胞疼痛危象期间的氨基酸特征显示与一氧化氮和能量代谢相关的显著改变。
Mol Genet Metab. 2022 Sep-Oct;137(1-2):146-152. doi: 10.1016/j.ymgme.2022.08.004. Epub 2022 Aug 20.
4
Arginine Therapy and Cardiopulmonary Hemodynamics in Hospitalized Children with Sickle Cell Anemia: A Prospective, Double-blinded, Randomized Placebo-controlled Clinical Trial.精氨酸治疗与镰状细胞贫血住院儿童的心肺血流动力学：一项前瞻性、双盲、随机安慰剂对照临床试验。
Am J Respir Crit Care Med. 2022 Jul 1;206(1):70-80. doi: 10.1164/rccm.202108-1930OC.
5
Safety of intravenous arginine therapy in children with sickle cell disease hospitalized for vaso-occlusive pain: A randomized placebo-controlled trial in progress.镰状细胞病患儿因血管闭塞性疼痛住院时静脉注射精氨酸治疗的安全性：一项正在进行的随机安慰剂对照试验。
Am J Hematol. 2022 Jan 1;97(1):E21-E24. doi: 10.1002/ajh.26396. Epub 2021 Nov 12.
6
Impact of oral -arginine supplementation on blood pressure dynamics in children with severe sickle cell vaso-occlusive crisis.口服精氨酸补充剂对重度镰状细胞血管闭塞性危象患儿血压动态的影响。
Am J Cardiovasc Dis. 2021 Feb 15;11(1):136-147. eCollection 2021.
7
Randomized control trial of oral arginine therapy for children with sickle cell anemia hospitalized for pain in Nigeria.尼日利亚一项针对因镰状细胞贫血住院疼痛儿童的口服精氨酸治疗的随机对照试验。
Am J Hematol. 2021 Jan;96(1):89-97. doi: 10.1002/ajh.26028. Epub 2020 Nov 20.
8
Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain.精氨酸治疗对镰状细胞病血管阻塞性疼痛患儿线粒体功能的影响。
Blood. 2020 Sep 17;136(12):1402-1406. doi: 10.1182/blood.2019003672.
9
Tyrosyl-tRNA synthetase: A potential kyotorphin synthetase in mammals.酪氨酰-tRNA 合成酶：哺乳动物中潜在的瓜氨酸合成酶。
Peptides. 2018 Mar;101:60-68. doi: 10.1016/j.peptides.2017.12.026. Epub 2017 Dec 28.
10
Arginine and citrulline for the treatment of MELAS syndrome.精氨酸和瓜氨酸用于治疗线粒体脑肌病伴乳酸血症和卒中样发作综合征
J Inborn Errors Metab Screen. 2017 Jan;5. doi: 10.1177/2326409817697399. Epub 2017 Mar 24.